FDA Adverse Event Injury Summary report: N

OT ULTRASMART METER

MDR report key: 3911401 · Received July 3, 2014

Report

Report Number
2939301-2014-16353
Event Type
Injury
Date Received
July 3, 2014
Date of Event
June 23, 2014
Report Date
June 29, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K021819
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PR, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6), 2014, THE LAY USER/ PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HIS ONETOUCH ULTRASMART METER POWERS OFF DURING USE. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE ALLEGED ISSUE BEGAN ON (B)(6) 2014 AROUND 9PM. THE PATIENT MANAGES HIS DIABETES WITH INJECTIONS (TYPE NOT SPECIFIED). IT IS NOT KNOWN IF THE PATIENT MADE CHANGES TO HIS USUAL MANAGEMENT ROUTINE. THE PATIENT DID NOT SPECIFY DEVELOPING SYMPTOMS; HOWEVER, ABOUT 1130PM THAT SAME EVENING, THE PATIENT REPORTEDLY WENT TO THE EMERGENCY ROOM (ER) AND OBTAINED A BLOOD GLUCOSE RESULT OF ¿40 MG/DL¿ WITH THE ER/ HOSPITAL METER. THE PATIENT WAS ADMINISTERED INTRAVENOUS (IV) GLUCOSE AS TREATMENT. THERE WAS NO INDICATION OF MISUSE. THE ALLEGED ISSUE WAS NOT RESOLVED AT THE TIME OF TROUBLESHOOTING. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE, THE PATIENT ALLEGEDLY OBTAINED A BLOOD GLUCOSE RESULT WITH AN ER/ HOSPITAL METER SUGGESTIVE OF A SERIOUS INJURY AND RECEIVED MEDICAL INTERVENTION FROM A HEALTH CARE PROFESSIONAL (HCP) AFTER THE REPORTED ISSUE BEGAN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
390586 OT ULTRASMART METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3503063

Patients

Seq Age Sex Outcome Treatment
1 55 YR Life Threatening| R